Skip to main content
. 2024 Jun 30;16(13):2421. doi: 10.3390/cancers16132421
NATC Neoadjuvant chemotherapy
pCR Pathological complete response
NRI Neoadjuvant response index
RCB Residual cancer burden
TNBC Triple-negative breast cancer
AJCC American Joint Committee on Cancer
ASCO American Society of Clinical Oncology
cN0 Clinical N0
N+ Node positive
RT Radiotherapy
BMI Body mass index
TILs Tumor-infiltrating lymphocytes
DFS Disease-free survival
DDFS Distant disease-free survival
OS Overall survival
BCSS Breast-cancer-specific survival
SD Standard deviation
CI Confidence intervals
HR Hazard ratio